Streetbeat News

Products Services

PTCT

PTC Therapeutics announced plans to continue the development and global commercialization of Upstaza, the first-ever approved gene therapy directly administered to the brain. This could potentially boost PTCT's stock price.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 8:19 pm

PTCT

PTC Therapeutics has discontinued its preclinical and early research gene therapy programs, potentially affecting the company's future pipeline.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 8:18 pm

INO

INOVIO has secured Orphan Drug Designation for INO-3107 from the European Commission for the treatment of Recurrent Respiratory Papillomatosis.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 8:15 pm

UTRS

Minerva Surgical has been granted U.S. Patent #11653972 for its medical systems and methods for resecting and extracting tissue. This patent could potentially strengthen Minerva's position in the medical device market.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 8:15 pm

PTCT

PTC Therapeutics announced that its MOVE-FA trial of Vatiquinone in patients with Friedreich Ataxia did not meet its primary endpoint. This may negatively impact the company's stock price.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 8:10 pm

GLPG

Galapagos has announced the start of a Phase 2 study with its selective TYK2 inhibitor, GLPG3667, in patients with dermatomyositis. This marks a significant step in the development of the drug.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 8:04 pm

PHAT

Phathom Pharmaceuticals has resubmitted its New Drug Application (NDA) for vonoprazan, a treatment for Erosive GERD, to the FDA. If approved, a combined U.S. commercial launch for Erosive GERD and H. pylori indications is planned for Q4 2023.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 8:02 pm

AI

The US Air Force has designated the Rapid Sustainment Office's Predictive Analytics and Decision Assistant (PANDA) as a system of record for Condition Based Maintenance Plus (CBM+). PANDA, an AI and ML tool for predictive maintenance, was developed in partnership with C3 AI.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 7:33 pm

EA

RBLX

YouTube star IShowSpeed accidentally purchased a virtual item in Roblox for 14 million Robux, equivalent to $125,000, during a live stream. The incident has gained significant attention on social media.

Portfolio Pulse from Franca Quarneti

May 23, 2023 | 7:31 pm

TSLA

Elon Musk announced that Tesla will likely choose another location for a new plant by the end of this year. He also mentioned that advertising agencies have lifted warnings on Twitter.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 7:17 pm